For more than a decade, investigators have been searching for a means of determining the
risk of individuals developing cancer by detecting rare oncogenic mutations. The …

Flt3 is a tyrosine kinase receptor expressed on hematopoietic cells. Activating mutations of
this receptor are encountered in over one-fourth of acute myelogenous leukemia (AML) …

Materials and methods The study group consisted of 12 acute leukemia patients who
underwent allo-SCT in the Department of Hematology and Bone Marrow Transplantation in …

Imatinib mesylate (IM) is the standard first‐line treatment for patients with chronic myeloid
leukemia (CML). Surprisingly, 2–15% of patients achieving a complete cytogenetic response …

Chronic myeloid leukemia (CML) is a rare disease in childhood which is almost exclusively
associated with bcr-abl p210 (M-bcr) rearrangements. It has been suggested that co …

由於外在環境的快速變遷, 尤其是技術環境更是一夕數變, 組織在面對此一嚴峻挑戰的同時,
為了求得時效與降低風險, 生存與發展, 採取合作研發模式取得所需知識以保競爭優勢 …

Sažetak Analiza mikrosatelita provedena je u svrhu ispitivanja njihove uloge u
transplantaciji hematopoetskih matičnih stanica. Prvi dio istraživanja ispitivao je mogućnost …

A complicating feature of the myeloproliferative disorders is the frequent overlap of clinical,
laboratory, and morphologic findings among the specific disorders. Cytogenetic and/or …

When the type I and type II E2A-HLF fusion proteins were compared in an in vitro assay,
there was no difference in the DNA-binding activities but there was a slight difference in the …